Global Gastrointestinal Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Page: 120

Published Date: 09 Jan 2022

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Gastrointestinal market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Gastrointestinal market size is estimated to be worth US$ 35710 million in 2021 and is forecast to a readjusted size of USD 44400 million by 2028 with a CAGR of 3.2% during review period. Pharmaceutical And Biotechnology Companies accounting for  % of the Gastrointestinal global market in 2021, is projected to value USD   million by 2028, growing at a  % CAGR in next six years. While Esophagus Diseases Drug segment is altered to a  % CAGR between 2022 and 2028.

Global key companies of Gastrointestinal include Zhejiang Asia-pacific Pharmaceutical, Yangtze Pharmaceutical Group, Tillotts Pharma, Solvay, and Shire Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over  % in 2021.

Market segmentation
Gastrointestinal market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Esophagus Diseases Drug
    Stomach Trouble Drug
    Colon Disease Drug
    Small Intestinal Diseases Drug
    Liver Disease Drug
    Pancreatic Disease Drug
    Gallbladder Disease Drug
    Other

Market segment by Application, can be divided into
    Pharmaceutical And Biotechnology Companies
    Hospital
    Pharmacy
    Outpatient Surgical Centers And Clinics
    Academic And Research Organizations
    Other

Market segment by players, this report covers
    Zhejiang Asia-pacific Pharmaceutical
    Yangtze Pharmaceutical Group
    Tillotts Pharma
    Solvay
    Shire Pharmaceuticals
    Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
    Shandong Luoxin Pharmaceutical Group
    Sanofi
    Roche
    Qilu Pharmaceutical Group
    Pfizer
    Nycomed (Takeda)
    Novartis
    Merck
    Livzon Pharmaceutical Group
    Johnson & Johnson
    Jiangsu Aosaikang Pharmaceutical
    Inner Mongolia Shuangqi Pharmaceutic
    Huadong Medicine
    GlaxoSmithKline
    Eli Lilly
    CTTQ
    CSPC
    Chengdu Tiantaishan Pharmaceutical
    Beijing Kaiyin Technology
    AstraZeneca
    Amgen
    Allergan
    AbbVie
    Abbott
    Fresenius
    Daewoong
    Dr.Falk Pharma
    Minophagen Pharmaceutical

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Gastrointestinal product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Gastrointestinal, with revenue, gross margin and global market share of Gastrointestinal from 2019 to 2022.
Chapter 3, the Gastrointestinal competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Gastrointestinal market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Gastrointestinal research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Gastrointestinal
    1.2 Classification of Gastrointestinal by Type
        1.2.1 Overview: Global Gastrointestinal Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Gastrointestinal Revenue Market Share by Type in 2021
        1.2.3 Esophagus Diseases Drug
        1.2.4 Stomach Trouble Drug
        1.2.5 Colon Disease Drug
        1.2.6 Small Intestinal Diseases Drug
        1.2.7 Liver Disease Drug
        1.2.8 Pancreatic Disease Drug
        1.2.9 Gallbladder Disease Drug
        1.2.10 Other
    1.3 Global Gastrointestinal Market by Application
        1.3.1 Overview: Global Gastrointestinal Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Pharmaceutical And Biotechnology Companies
        1.3.3 Hospital
        1.3.4 Pharmacy
        1.3.5 Outpatient Surgical Centers And Clinics
        1.3.6 Academic And Research Organizations
        1.3.7 Other
    1.4 Global Gastrointestinal Market Size & Forecast
    1.5 Global Gastrointestinal Market Size and Forecast by Region
        1.5.1 Global Gastrointestinal Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Gastrointestinal Market Size by Region, (2017-2022)
        1.5.3 North America Gastrointestinal Market Size and Prospect (2017-2028)
        1.5.4 Europe Gastrointestinal Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Gastrointestinal Market Size and Prospect (2017-2028)
        1.5.6 South America Gastrointestinal Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Gastrointestinal Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Gastrointestinal Market Drivers
        1.6.2 Gastrointestinal Market Restraints
        1.6.3 Gastrointestinal Trends Analysis

2 Company Profiles
    2.1 Zhejiang Asia-pacific Pharmaceutical
        2.1.1 Zhejiang Asia-pacific Pharmaceutical Details
        2.1.2 Zhejiang Asia-pacific Pharmaceutical Major Business
        2.1.3 Zhejiang Asia-pacific Pharmaceutical Gastrointestinal Product and Solutions
        2.1.4 Zhejiang Asia-pacific Pharmaceutical Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Zhejiang Asia-pacific Pharmaceutical Recent Developments and Future Plans
    2.2 Yangtze Pharmaceutical Group
        2.2.1 Yangtze Pharmaceutical Group Details
        2.2.2 Yangtze Pharmaceutical Group Major Business
        2.2.3 Yangtze Pharmaceutical Group Gastrointestinal Product and Solutions
        2.2.4 Yangtze Pharmaceutical Group Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Yangtze Pharmaceutical Group Recent Developments and Future Plans
    2.3 Tillotts Pharma
        2.3.1 Tillotts Pharma Details
        2.3.2 Tillotts Pharma Major Business
        2.3.3 Tillotts Pharma Gastrointestinal Product and Solutions
        2.3.4 Tillotts Pharma Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Tillotts Pharma Recent Developments and Future Plans
    2.4 Solvay
        2.4.1 Solvay Details
        2.4.2 Solvay Major Business
        2.4.3 Solvay Gastrointestinal Product and Solutions
        2.4.4 Solvay Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Solvay Recent Developments and Future Plans
    2.5 Shire Pharmaceuticals
        2.5.1 Shire Pharmaceuticals Details
        2.5.2 Shire Pharmaceuticals Major Business
        2.5.3 Shire Pharmaceuticals Gastrointestinal Product and Solutions
        2.5.4 Shire Pharmaceuticals Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Shire Pharmaceuticals Recent Developments and Future Plans
    2.6 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
        2.6.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Details
        2.6.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Major Business
        2.6.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Gastrointestinal Product and Solutions
        2.6.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Developments and Future Plans
    2.7 Shandong Luoxin Pharmaceutical Group
        2.7.1 Shandong Luoxin Pharmaceutical Group Details
        2.7.2 Shandong Luoxin Pharmaceutical Group Major Business
        2.7.3 Shandong Luoxin Pharmaceutical Group Gastrointestinal Product and Solutions
        2.7.4 Shandong Luoxin Pharmaceutical Group Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Shandong Luoxin Pharmaceutical Group Recent Developments and Future Plans
    2.8 Sanofi
        2.8.1 Sanofi Details
        2.8.2 Sanofi Major Business
        2.8.3 Sanofi Gastrointestinal Product and Solutions
        2.8.4 Sanofi Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Sanofi Recent Developments and Future Plans
    2.9 Roche
        2.9.1 Roche Details
        2.9.2 Roche Major Business
        2.9.3 Roche Gastrointestinal Product and Solutions
        2.9.4 Roche Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Roche Recent Developments and Future Plans
    2.10 Qilu Pharmaceutical Group
        2.10.1 Qilu Pharmaceutical Group Details
        2.10.2 Qilu Pharmaceutical Group Major Business
        2.10.3 Qilu Pharmaceutical Group Gastrointestinal Product and Solutions
        2.10.4 Qilu Pharmaceutical Group Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Qilu Pharmaceutical Group Recent Developments and Future Plans
    2.11 Pfizer
        2.11.1 Pfizer Details
        2.11.2 Pfizer Major Business
        2.11.3 Pfizer Gastrointestinal Product and Solutions
        2.11.4 Pfizer Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Pfizer Recent Developments and Future Plans
    2.12 Nycomed (Takeda)
        2.12.1 Nycomed (Takeda) Details
        2.12.2 Nycomed (Takeda) Major Business
        2.12.3 Nycomed (Takeda) Gastrointestinal Product and Solutions
        2.12.4 Nycomed (Takeda) Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 Nycomed (Takeda) Recent Developments and Future Plans
    2.13 Novartis
        2.13.1 Novartis Details
        2.13.2 Novartis Major Business
        2.13.3 Novartis Gastrointestinal Product and Solutions
        2.13.4 Novartis Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 Novartis Recent Developments and Future Plans
    2.14 Merck
        2.14.1 Merck Details
        2.14.2 Merck Major Business
        2.14.3 Merck Gastrointestinal Product and Solutions
        2.14.4 Merck Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.14.5 Merck Recent Developments and Future Plans
    2.15 Livzon Pharmaceutical Group
        2.15.1 Livzon Pharmaceutical Group Details
        2.15.2 Livzon Pharmaceutical Group Major Business
        2.15.3 Livzon Pharmaceutical Group Gastrointestinal Product and Solutions
        2.15.4 Livzon Pharmaceutical Group Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.15.5 Livzon Pharmaceutical Group Recent Developments and Future Plans
    2.16 Johnson & Johnson
        2.16.1 Johnson & Johnson Details
        2.16.2 Johnson & Johnson Major Business
        2.16.3 Johnson & Johnson Gastrointestinal Product and Solutions
        2.16.4 Johnson & Johnson Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.16.5 Johnson & Johnson Recent Developments and Future Plans
    2.17 Jiangsu Aosaikang Pharmaceutical
        2.17.1 Jiangsu Aosaikang Pharmaceutical Details
        2.17.2 Jiangsu Aosaikang Pharmaceutical Major Business
        2.17.3 Jiangsu Aosaikang Pharmaceutical Gastrointestinal Product and Solutions
        2.17.4 Jiangsu Aosaikang Pharmaceutical Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.17.5 Jiangsu Aosaikang Pharmaceutical Recent Developments and Future Plans
    2.18 Inner Mongolia Shuangqi Pharmaceutic
        2.18.1 Inner Mongolia Shuangqi Pharmaceutic Details
        2.18.2 Inner Mongolia Shuangqi Pharmaceutic Major Business
        2.18.3 Inner Mongolia Shuangqi Pharmaceutic Gastrointestinal Product and Solutions
        2.18.4 Inner Mongolia Shuangqi Pharmaceutic Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.18.5 Inner Mongolia Shuangqi Pharmaceutic Recent Developments and Future Plans
    2.19 Huadong Medicine
        2.19.1 Huadong Medicine Details
        2.19.2 Huadong Medicine Major Business
        2.19.3 Huadong Medicine Gastrointestinal Product and Solutions
        2.19.4 Huadong Medicine Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.19.5 Huadong Medicine Recent Developments and Future Plans
    2.20 GlaxoSmithKline
        2.20.1 GlaxoSmithKline Details
        2.20.2 GlaxoSmithKline Major Business
        2.20.3 GlaxoSmithKline Gastrointestinal Product and Solutions
        2.20.4 GlaxoSmithKline Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.20.5 GlaxoSmithKline Recent Developments and Future Plans
    2.21 Eli Lilly
        2.21.1 Eli Lilly Details
        2.21.2 Eli Lilly Major Business
        2.21.3 Eli Lilly Gastrointestinal Product and Solutions
        2.21.4 Eli Lilly Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.21.5 Eli Lilly Recent Developments and Future Plans
    2.22 CTTQ
        2.22.1 CTTQ Details
        2.22.2 CTTQ Major Business
        2.22.3 CTTQ Gastrointestinal Product and Solutions
        2.22.4 CTTQ Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.22.5 CTTQ Recent Developments and Future Plans
    2.23 CSPC
        2.23.1 CSPC Details
        2.23.2 CSPC Major Business
        2.23.3 CSPC Gastrointestinal Product and Solutions
        2.23.4 CSPC Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.23.5 CSPC Recent Developments and Future Plans
    2.24 Chengdu Tiantaishan Pharmaceutical
        2.24.1 Chengdu Tiantaishan Pharmaceutical Details
        2.24.2 Chengdu Tiantaishan Pharmaceutical Major Business
        2.24.3 Chengdu Tiantaishan Pharmaceutical Gastrointestinal Product and Solutions
        2.24.4 Chengdu Tiantaishan Pharmaceutical Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.24.5 Chengdu Tiantaishan Pharmaceutical Recent Developments and Future Plans
    2.25 Beijing Kaiyin Technology
        2.25.1 Beijing Kaiyin Technology Details
        2.25.2 Beijing Kaiyin Technology Major Business
        2.25.3 Beijing Kaiyin Technology Gastrointestinal Product and Solutions
        2.25.4 Beijing Kaiyin Technology Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.25.5 Beijing Kaiyin Technology Recent Developments and Future Plans
    2.26 AstraZeneca
        2.26.1 AstraZeneca Details
        2.26.2 AstraZeneca Major Business
        2.26.3 AstraZeneca Gastrointestinal Product and Solutions
        2.26.4 AstraZeneca Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.26.5 AstraZeneca Recent Developments and Future Plans
    2.27 Amgen
        2.27.1 Amgen Details
        2.27.2 Amgen Major Business
        2.27.3 Amgen Gastrointestinal Product and Solutions
        2.27.4 Amgen Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.27.5 Amgen Recent Developments and Future Plans
    2.28 Allergan
        2.28.1 Allergan Details
        2.28.2 Allergan Major Business
        2.28.3 Allergan Gastrointestinal Product and Solutions
        2.28.4 Allergan Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.28.5 Allergan Recent Developments and Future Plans
    2.29 AbbVie
        2.29.1 AbbVie Details
        2.29.2 AbbVie Major Business
        2.29.3 AbbVie Gastrointestinal Product and Solutions
        2.29.4 AbbVie Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.29.5 AbbVie Recent Developments and Future Plans
    2.30 Abbott
        2.30.1 Abbott Details
        2.30.2 Abbott Major Business
        2.30.3 Abbott Gastrointestinal Product and Solutions
        2.30.4 Abbott Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.30.5 Abbott Recent Developments and Future Plans
    2.31 Fresenius
        2.31.1 Fresenius Details
        2.31.2 Fresenius Major Business
        2.31.3 Fresenius Gastrointestinal Product and Solutions
        2.31.4 Fresenius Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.31.5 Fresenius Recent Developments and Future Plans
    2.32 Daewoong
        2.32.1 Daewoong Details
        2.32.2 Daewoong Major Business
        2.32.3 Daewoong Gastrointestinal Product and Solutions
        2.32.4 Daewoong Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.32.5 Daewoong Recent Developments and Future Plans
    2.33 Dr.Falk Pharma
        2.33.1 Dr.Falk Pharma Details
        2.33.2 Dr.Falk Pharma Major Business
        2.33.3 Dr.Falk Pharma Gastrointestinal Product and Solutions
        2.33.4 Dr.Falk Pharma Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.33.5 Dr.Falk Pharma Recent Developments and Future Plans
    2.34 Minophagen Pharmaceutical
        2.34.1 Minophagen Pharmaceutical Details
        2.34.2 Minophagen Pharmaceutical Major Business
        2.34.3 Minophagen Pharmaceutical Gastrointestinal Product and Solutions
        2.34.4 Minophagen Pharmaceutical Gastrointestinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.34.5 Minophagen Pharmaceutical Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Gastrointestinal Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Gastrointestinal Players Market Share in 2021
        3.2.2 Top 10 Gastrointestinal Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Gastrointestinal Players Head Office, Products and Services Provided
    3.4 Gastrointestinal Mergers & Acquisitions
    3.5 Gastrointestinal New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Gastrointestinal Revenue and Market Share by Type (2017-2022)
    4.2 Global Gastrointestinal Market Forecast by Type (2023-2028)

5 Market Size Segment by Application
    5.1 Global Gastrointestinal Revenue Market Share by Application (2017-2022)
    5.2 Global Gastrointestinal Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application
    6.1 North America Gastrointestinal Revenue by Type (2017-2028)
    6.2 North America Gastrointestinal Revenue by Application (2017-2028)
    6.3 North America Gastrointestinal Market Size by Country
        6.3.1 North America Gastrointestinal Revenue by Country (2017-2028)
        6.3.2 United States Gastrointestinal Market Size and Forecast (2017-2028)
        6.3.3 Canada Gastrointestinal Market Size and Forecast (2017-2028)
        6.3.4 Mexico Gastrointestinal Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application
    7.1 Europe Gastrointestinal Revenue by Type (2017-2028)
    7.2 Europe Gastrointestinal Revenue by Application (2017-2028)
    7.3 Europe Gastrointestinal Market Size by Country
        7.3.1 Europe Gastrointestinal Revenue by Country (2017-2028)
        7.3.2 Germany Gastrointestinal Market Size and Forecast (2017-2028)
        7.3.3 France Gastrointestinal Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Gastrointestinal Market Size and Forecast (2017-2028)
        7.3.5 Russia Gastrointestinal Market Size and Forecast (2017-2028)
        7.3.6 Italy Gastrointestinal Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Gastrointestinal Revenue by Type (2017-2028)
    8.2 Asia-Pacific Gastrointestinal Revenue by Application (2017-2028)
    8.3 Asia-Pacific Gastrointestinal Market Size by Region
        8.3.1 Asia-Pacific Gastrointestinal Revenue by Region (2017-2028)
        8.3.2 China Gastrointestinal Market Size and Forecast (2017-2028)
        8.3.3 Japan Gastrointestinal Market Size and Forecast (2017-2028)
        8.3.4 South Korea Gastrointestinal Market Size and Forecast (2017-2028)
        8.3.5 India Gastrointestinal Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Gastrointestinal Market Size and Forecast (2017-2028)
        8.3.7 Australia Gastrointestinal Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application
    9.1 South America Gastrointestinal Revenue by Type (2017-2028)
    9.2 South America Gastrointestinal Revenue by Application (2017-2028)
    9.3 South America Gastrointestinal Market Size by Country
        9.3.1 South America Gastrointestinal Revenue by Country (2017-2028)
        9.3.2 Brazil Gastrointestinal Market Size and Forecast (2017-2028)
        9.3.3 Argentina Gastrointestinal Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Gastrointestinal Revenue by Type (2017-2028)
    10.2 Middle East & Africa Gastrointestinal Revenue by Application (2017-2028)
    10.3 Middle East & Africa Gastrointestinal Market Size by Country
        10.3.1 Middle East & Africa Gastrointestinal Revenue by Country (2017-2028)
        10.3.2 Turkey Gastrointestinal Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Gastrointestinal Market Size and Forecast (2017-2028)
        10.3.4 UAE Gastrointestinal Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Gastrointestinal Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
    Table 2. Global Gastrointestinal Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
    Table 3. Global Market Gastrointestinal Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
    Table 4. Global Gastrointestinal Revenue (USD Million) by Region (2017-2022)
    Table 5. Global Gastrointestinal Revenue Market Share by Region (2023-2028)
    Table 6. Zhejiang Asia-pacific Pharmaceutical Corporate Information, Head Office, and Major Competitors
    Table 7. Zhejiang Asia-pacific Pharmaceutical Major Business
    Table 8. Zhejiang Asia-pacific Pharmaceutical Gastrointestinal Product and Solutions
    Table 9. Zhejiang Asia-pacific Pharmaceutical Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 10. Yangtze Pharmaceutical Group Corporate Information, Head Office, and Major Competitors
    Table 11. Yangtze Pharmaceutical Group Major Business
    Table 12. Yangtze Pharmaceutical Group Gastrointestinal Product and Solutions
    Table 13. Yangtze Pharmaceutical Group Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 14. Tillotts Pharma Corporate Information, Head Office, and Major Competitors
    Table 15. Tillotts Pharma Major Business
    Table 16. Tillotts Pharma Gastrointestinal Product and Solutions
    Table 17. Tillotts Pharma Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 18. Solvay Corporate Information, Head Office, and Major Competitors
    Table 19. Solvay Major Business
    Table 20. Solvay Gastrointestinal Product and Solutions
    Table 21. Solvay Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 22. Shire Pharmaceuticals Corporate Information, Head Office, and Major Competitors
    Table 23. Shire Pharmaceuticals Major Business
    Table 24. Shire Pharmaceuticals Gastrointestinal Product and Solutions
    Table 25. Shire Pharmaceuticals Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 26. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Corporate Information, Head Office, and Major Competitors
    Table 27. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Major Business
    Table 28. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Gastrointestinal Product and Solutions
    Table 29. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 30. Shandong Luoxin Pharmaceutical Group Corporate Information, Head Office, and Major Competitors
    Table 31. Shandong Luoxin Pharmaceutical Group Major Business
    Table 32. Shandong Luoxin Pharmaceutical Group Gastrointestinal Product and Solutions
    Table 33. Shandong Luoxin Pharmaceutical Group Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 34. Sanofi Corporate Information, Head Office, and Major Competitors
    Table 35. Sanofi Major Business
    Table 36. Sanofi Gastrointestinal Product and Solutions
    Table 37. Sanofi Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 38. Roche Corporate Information, Head Office, and Major Competitors
    Table 39. Roche Major Business
    Table 40. Roche Gastrointestinal Product and Solutions
    Table 41. Roche Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 42. Qilu Pharmaceutical Group Corporate Information, Head Office, and Major Competitors
    Table 43. Qilu Pharmaceutical Group Major Business
    Table 44. Qilu Pharmaceutical Group Gastrointestinal Product and Solutions
    Table 45. Qilu Pharmaceutical Group Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 46. Pfizer Corporate Information, Head Office, and Major Competitors
    Table 47. Pfizer Major Business
    Table 48. Pfizer Gastrointestinal Product and Solutions
    Table 49. Pfizer Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 50. Nycomed (Takeda) Corporate Information, Head Office, and Major Competitors
    Table 51. Nycomed (Takeda) Major Business
    Table 52. Nycomed (Takeda) Gastrointestinal Product and Solutions
    Table 53. Nycomed (Takeda) Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 54. Novartis Corporate Information, Head Office, and Major Competitors
    Table 55. Novartis Major Business
    Table 56. Novartis Gastrointestinal Product and Solutions
    Table 57. Novartis Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 58. Merck Corporate Information, Head Office, and Major Competitors
    Table 59. Merck Major Business
    Table 60. Merck Gastrointestinal Product and Solutions
    Table 61. Merck Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 62. Livzon Pharmaceutical Group Corporate Information, Head Office, and Major Competitors
    Table 63. Livzon Pharmaceutical Group Major Business
    Table 64. Livzon Pharmaceutical Group Gastrointestinal Product and Solutions
    Table 65. Livzon Pharmaceutical Group Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 66. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
    Table 67. Johnson & Johnson Major Business
    Table 68. Johnson & Johnson Gastrointestinal Product and Solutions
    Table 69. Johnson & Johnson Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 70. Jiangsu Aosaikang Pharmaceutical Corporate Information, Head Office, and Major Competitors
    Table 71. Jiangsu Aosaikang Pharmaceutical Major Business
    Table 72. Jiangsu Aosaikang Pharmaceutical Gastrointestinal Product and Solutions
    Table 73. Jiangsu Aosaikang Pharmaceutical Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 74. Inner Mongolia Shuangqi Pharmaceutic Corporate Information, Head Office, and Major Competitors
    Table 75. Inner Mongolia Shuangqi Pharmaceutic Major Business
    Table 76. Inner Mongolia Shuangqi Pharmaceutic Gastrointestinal Product and Solutions
    Table 77. Inner Mongolia Shuangqi Pharmaceutic Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 78. Huadong Medicine Corporate Information, Head Office, and Major Competitors
    Table 79. Huadong Medicine Major Business
    Table 80. Huadong Medicine Gastrointestinal Product and Solutions
    Table 81. Huadong Medicine Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 82. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
    Table 83. GlaxoSmithKline Major Business
    Table 84. GlaxoSmithKline Gastrointestinal Product and Solutions
    Table 85. GlaxoSmithKline Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 86. Eli Lilly Corporate Information, Head Office, and Major Competitors
    Table 87. Eli Lilly Major Business
    Table 88. Eli Lilly Gastrointestinal Product and Solutions
    Table 89. Eli Lilly Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 90. CTTQ Corporate Information, Head Office, and Major Competitors
    Table 91. CTTQ Major Business
    Table 92. CTTQ Gastrointestinal Product and Solutions
    Table 93. CTTQ Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 94. CSPC Corporate Information, Head Office, and Major Competitors
    Table 95. CSPC Major Business
    Table 96. CSPC Gastrointestinal Product and Solutions
    Table 97. CSPC Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 98. Chengdu Tiantaishan Pharmaceutical Corporate Information, Head Office, and Major Competitors
    Table 99. Chengdu Tiantaishan Pharmaceutical Major Business
    Table 100. Chengdu Tiantaishan Pharmaceutical Gastrointestinal Product and Solutions
    Table 101. Chengdu Tiantaishan Pharmaceutical Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 102. Beijing Kaiyin Technology Corporate Information, Head Office, and Major Competitors
    Table 103. Beijing Kaiyin Technology Major Business
    Table 104. Beijing Kaiyin Technology Gastrointestinal Product and Solutions
    Table 105. Beijing Kaiyin Technology Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 106. AstraZeneca Corporate Information, Head Office, and Major Competitors
    Table 107. AstraZeneca Major Business
    Table 108. AstraZeneca Gastrointestinal Product and Solutions
    Table 109. AstraZeneca Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 110. Amgen Corporate Information, Head Office, and Major Competitors
    Table 111. Amgen Major Business
    Table 112. Amgen Gastrointestinal Product and Solutions
    Table 113. Amgen Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 114. Allergan Corporate Information, Head Office, and Major Competitors
    Table 115. Allergan Major Business
    Table 116. Allergan Gastrointestinal Product and Solutions
    Table 117. Allergan Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 118. AbbVie Corporate Information, Head Office, and Major Competitors
    Table 119. AbbVie Major Business
    Table 120. AbbVie Gastrointestinal Product and Solutions
    Table 121. AbbVie Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 122. Abbott Corporate Information, Head Office, and Major Competitors
    Table 123. Abbott Major Business
    Table 124. Abbott Gastrointestinal Product and Solutions
    Table 125. Abbott Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 126. Fresenius Corporate Information, Head Office, and Major Competitors
    Table 127. Fresenius Major Business
    Table 128. Fresenius Gastrointestinal Product and Solutions
    Table 129. Fresenius Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 130. Daewoong Corporate Information, Head Office, and Major Competitors
    Table 131. Daewoong Major Business
    Table 132. Daewoong Gastrointestinal Product and Solutions
    Table 133. Daewoong Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 134. Dr.Falk Pharma Corporate Information, Head Office, and Major Competitors
    Table 135. Dr.Falk Pharma Major Business
    Table 136. Dr.Falk Pharma Gastrointestinal Product and Solutions
    Table 137. Dr.Falk Pharma Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 138. Minophagen Pharmaceutical Corporate Information, Head Office, and Major Competitors
    Table 139. Minophagen Pharmaceutical Major Business
    Table 140. Minophagen Pharmaceutical Gastrointestinal Product and Solutions
    Table 141. Minophagen Pharmaceutical Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 142. Global Gastrointestinal Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
    Table 143. Global Gastrointestinal Revenue Share by Players (2019, 2020, 2021, and 2022)
    Table 144. Breakdown of Gastrointestinal by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 145. Gastrointestinal Players Head Office, Products and Services Provided
    Table 146. Gastrointestinal Mergers & Acquisitions in the Past Five Years
    Table 147. Gastrointestinal New Entrants and Expansion Plans
    Table 148. Global Gastrointestinal Revenue (USD Million) by Type (2017-2022)
    Table 149. Global Gastrointestinal Revenue Share by Type (2017-2022)
    Table 150. Global Gastrointestinal Revenue Forecast by Type (2023-2028)
    Table 151. Global Gastrointestinal Revenue by Application (2017-2022)
    Table 152. Global Gastrointestinal Revenue Forecast by Application (2023-2028)
    Table 153. North America Gastrointestinal Revenue by Type (2017-2022) & (USD Million)
    Table 154. North America Gastrointestinal Revenue by Type (2023-2028) & (USD Million)
    Table 155. North America Gastrointestinal Revenue by Application (2017-2022) & (USD Million)
    Table 156. North America Gastrointestinal Revenue by Application (2023-2028) & (USD Million)
    Table 157. North America Gastrointestinal Revenue by Country (2017-2022) & (USD Million)
    Table 158. North America Gastrointestinal Revenue by Country (2023-2028) & (USD Million)
    Table 159. Europe Gastrointestinal Revenue by Type (2017-2022) & (USD Million)
    Table 160. Europe Gastrointestinal Revenue by Type (2023-2028) & (USD Million)
    Table 161. Europe Gastrointestinal Revenue by Application (2017-2022) & (USD Million)
    Table 162. Europe Gastrointestinal Revenue by Application (2023-2028) & (USD Million)
    Table 163. Europe Gastrointestinal Revenue by Country (2017-2022) & (USD Million)
    Table 164. Europe Gastrointestinal Revenue by Country (2023-2028) & (USD Million)
    Table 165. Asia-Pacific Gastrointestinal Revenue by Type (2017-2022) & (USD Million)
    Table 166. Asia-Pacific Gastrointestinal Revenue by Type (2023-2028) & (USD Million)
    Table 167. Asia-Pacific Gastrointestinal Revenue by Application (2017-2022) & (USD Million)
    Table 168. Asia-Pacific Gastrointestinal Revenue by Application (2023-2028) & (USD Million)
    Table 169. Asia-Pacific Gastrointestinal Revenue by Region (2017-2022) & (USD Million)
    Table 170. Asia-Pacific Gastrointestinal Revenue by Region (2023-2028) & (USD Million)
    Table 171. South America Gastrointestinal Revenue by Type (2017-2022) & (USD Million)
    Table 172. South America Gastrointestinal Revenue by Type (2023-2028) & (USD Million)
    Table 173. South America Gastrointestinal Revenue by Application (2017-2022) & (USD Million)
    Table 174. South America Gastrointestinal Revenue by Application (2023-2028) & (USD Million)
    Table 175. South America Gastrointestinal Revenue by Country (2017-2022) & (USD Million)
    Table 176. South America Gastrointestinal Revenue by Country (2023-2028) & (USD Million)
    Table 177. Middle East & Africa Gastrointestinal Revenue by Type (2017-2022) & (USD Million)
    Table 178. Middle East & Africa Gastrointestinal Revenue by Type (2023-2028) & (USD Million)
    Table 179. Middle East & Africa Gastrointestinal Revenue by Application (2017-2022) & (USD Million)
    Table 180. Middle East & Africa Gastrointestinal Revenue by Application (2023-2028) & (USD Million)
    Table 181. Middle East & Africa Gastrointestinal Revenue by Country (2017-2022) & (USD Million)
    Table 182. Middle East & Africa Gastrointestinal Revenue by Country (2023-2028) & (USD Million)
List of Figures
    Figure 1. Gastrointestinal Picture
    Figure 2. Global Gastrointestinal Revenue Market Share by Type in 2021
    Figure 3. Esophagus Diseases Drug
    Figure 4. Stomach Trouble Drug
    Figure 5. Colon Disease Drug
    Figure 6. Small Intestinal Diseases Drug
    Figure 7. Liver Disease Drug
    Figure 8. Pancreatic Disease Drug
    Figure 9. Gallbladder Disease Drug
    Figure 10. Other
    Figure 11. Gastrointestinal Revenue Market Share by Application in 2021
    Figure 12. Pharmaceutical And Biotechnology Companies Picture
    Figure 13. Hospital Picture
    Figure 14. Pharmacy Picture
    Figure 15. Outpatient Surgical Centers And Clinics Picture
    Figure 16. Academic And Research Organizations Picture
    Figure 17. Other Picture
    Figure 18. Global Gastrointestinal Market Size, (USD Million): 2017 VS 2021 VS 2028
    Figure 19. Global Gastrointestinal Revenue and Forecast (2017-2028) & (USD Million)
    Figure 20. Global Gastrointestinal Revenue Market Share by Region (2017-2028)
    Figure 21. Global Gastrointestinal Revenue Market Share by Region in 2021
    Figure 22. North America Gastrointestinal Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 23. Europe Gastrointestinal Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 24. Asia-Pacific Gastrointestinal Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 25. South America Gastrointestinal Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 26. Middle East and Africa Gastrointestinal Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 27. Gastrointestinal Market Drivers
    Figure 28. Gastrointestinal Market Restraints
    Figure 29. Gastrointestinal Market Trends
    Figure 30. Zhejiang Asia-pacific Pharmaceutical Recent Developments and Future Plans
    Figure 31. Yangtze Pharmaceutical Group Recent Developments and Future Plans
    Figure 32. Tillotts Pharma Recent Developments and Future Plans
    Figure 33. Solvay Recent Developments and Future Plans
    Figure 34. Shire Pharmaceuticals Recent Developments and Future Plans
    Figure 35. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Developments and Future Plans
    Figure 36. Shandong Luoxin Pharmaceutical Group Recent Developments and Future Plans
    Figure 37. Sanofi Recent Developments and Future Plans
    Figure 38. Roche Recent Developments and Future Plans
    Figure 39. Qilu Pharmaceutical Group Recent Developments and Future Plans
    Figure 40. Pfizer Recent Developments and Future Plans
    Figure 41. Nycomed (Takeda) Recent Developments and Future Plans
    Figure 42. Novartis Recent Developments and Future Plans
    Figure 43. Merck Recent Developments and Future Plans
    Figure 44. Livzon Pharmaceutical Group Recent Developments and Future Plans
    Figure 45. Johnson & Johnson Recent Developments and Future Plans
    Figure 46. Jiangsu Aosaikang Pharmaceutical Recent Developments and Future Plans
    Figure 47. Inner Mongolia Shuangqi Pharmaceutic Recent Developments and Future Plans
    Figure 48. Huadong Medicine Recent Developments and Future Plans
    Figure 49. GlaxoSmithKline Recent Developments and Future Plans
    Figure 50. Eli Lilly Recent Developments and Future Plans
    Figure 51. CTTQ Recent Developments and Future Plans
    Figure 52. CSPC Recent Developments and Future Plans
    Figure 53. Chengdu Tiantaishan Pharmaceutical Recent Developments and Future Plans
    Figure 54. Beijing Kaiyin Technology Recent Developments and Future Plans
    Figure 55. AstraZeneca Recent Developments and Future Plans
    Figure 56. Amgen Recent Developments and Future Plans
    Figure 57. Allergan Recent Developments and Future Plans
    Figure 58. AbbVie Recent Developments and Future Plans
    Figure 59. Abbott Recent Developments and Future Plans
    Figure 60. Fresenius Recent Developments and Future Plans
    Figure 61. Daewoong Recent Developments and Future Plans
    Figure 62. Dr.Falk Pharma Recent Developments and Future Plans
    Figure 63. Minophagen Pharmaceutical Recent Developments and Future Plans
    Figure 64. Global Gastrointestinal Revenue Share by Players in 2021
    Figure 65. Gastrointestinal Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
    Figure 66. Global Top 3 Players Gastrointestinal Revenue Market Share in 2021
    Figure 67. Global Top 10 Players Gastrointestinal Revenue Market Share in 2021
    Figure 68. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
    Figure 69. Global Gastrointestinal Revenue Share by Type in 2021
    Figure 70. Global Gastrointestinal Market Share Forecast by Type (2023-2028)
    Figure 71. Global Gastrointestinal Revenue Share by Application in 2021
    Figure 72. Global Gastrointestinal Market Share Forecast by Application (2023-2028)
    Figure 73. North America Gastrointestinal Sales Market Share by Type (2017-2028)
    Figure 74. North America Gastrointestinal Sales Market Share by Application (2017-2028)
    Figure 75. North America Gastrointestinal Revenue Market Share by Country (2017-2028)
    Figure 76. United States Gastrointestinal Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 77. Canada Gastrointestinal Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 78. Mexico Gastrointestinal Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 79. Europe Gastrointestinal Sales Market Share by Type (2017-2028)
    Figure 80. Europe Gastrointestinal Sales Market Share by Application (2017-2028)
    Figure 81. Europe Gastrointestinal Revenue Market Share by Country (2017-2028)
    Figure 82. Germany Gastrointestinal Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 83. France Gastrointestinal Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 84. United Kingdom Gastrointestinal Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 85. Russia Gastrointestinal Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 86. Italy Gastrointestinal Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 87. Asia-Pacific Gastrointestinal Sales Market Share by Type (2017-2028)
    Figure 88. Asia-Pacific Gastrointestinal Sales Market Share by Application (2017-2028)
    Figure 89. Asia-Pacific Gastrointestinal Revenue Market Share by Region (2017-2028)
    Figure 90. China Gastrointestinal Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 91. Japan Gastrointestinal Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 92. South Korea Gastrointestinal Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 93. India Gastrointestinal Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 94. Southeast Asia Gastrointestinal Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 95. Australia Gastrointestinal Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 96. South America Gastrointestinal Sales Market Share by Type (2017-2028)
    Figure 97. South America Gastrointestinal Sales Market Share by Application (2017-2028)
    Figure 98. South America Gastrointestinal Revenue Market Share by Country (2017-2028)
    Figure 99. Brazil Gastrointestinal Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 100. Argentina Gastrointestinal Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 101. Middle East and Africa Gastrointestinal Sales Market Share by Type (2017-2028)
    Figure 102. Middle East and Africa Gastrointestinal Sales Market Share by Application (2017-2028)
    Figure 103. Middle East and Africa Gastrointestinal Revenue Market Share by Country (2017-2028)
    Figure 104. Turkey Gastrointestinal Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 105. Saudi Arabia Gastrointestinal Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 106. UAE Gastrointestinal Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 107. Methodology
    Figure 108. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Zhejiang Asia-pacific Pharmaceutical
Yangtze Pharmaceutical Group
Tillotts Pharma
Solvay
Shire Pharmaceuticals
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Shandong Luoxin Pharmaceutical Group
Sanofi
Roche
Qilu Pharmaceutical Group
Pfizer
Nycomed (Takeda)
Novartis
Merck
Livzon Pharmaceutical Group
Johnson & Johnson
Jiangsu Aosaikang Pharmaceutical
Inner Mongolia Shuangqi Pharmaceutic
Huadong Medicine
GlaxoSmithKline
Eli Lilly
CTTQ
CSPC
Chengdu Tiantaishan Pharmaceutical
Beijing Kaiyin Technology
AstraZeneca
Amgen
Allergan
AbbVie
Abbott
Fresenius
Daewoong
Dr.Falk Pharma
Minophagen Pharmaceutical

Related Reports

Global Gastrointestinal Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Gastrointestinal Market 2021 by Company, Regions, Type and Application, Forecast to 2026

date 06 Jun 2021

date Pharma & Healthcare

The Gastrointestinal market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Gastrointestinal Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Gastrointestinal Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.

Global Gastrointestinal Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Gastrointestinal Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Gastrointestinal market size was valued at USD 35710 million in 2023 and is forecast to a readjusted size of USD 44400 million by 2030 with a CAGR of 3.2% during review period.

Global Gastrointestinal Supply, Demand and Key Producers, 2024-2030

Global Gastrointestinal Supply, Demand and Key Producers, 2024-2030

date 20 Feb 2024

date Pharma & Healthcare

The global Gastrointestinal market size is expected to reach $ 44400 million by 2030, rising at a market growth of 3.2% CAGR during the forecast period (2024-2030).

Product Tags

gastrointestinal

gastrointestinal endoscopic device

gastrointestinal stromal tumor molecular diagnostics

gastrointestinal countries

gastrointestinal bleeding therapeutic devices

gastrointestinal treatment ozone therapy unit

gastrointestinal surgery staplers

gastrointestinal surgery suture thread

gastrointestinal bleeding treatment

otc gastrointestinal products

prescription gastrointestinal drugs

gastrointestinal cancer devices

gastrointestinal cancer drugs

gastrointestinal therapeutics diagnostics

gastrointestinal gi stents

gastrointestinal gi stent

gastrointestinal cancer treatment

gastrointestinal disorder therapeutics

gastrointestinal electrocardiograph

gastrointestinal infection testing

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>